Moul J - Search Results

1

Optimizing treatment for men with advanced prostate cancer: expert recommendations and the multidisciplinary approach.

Fitzpatrick JM, Anderson J, Sternberg CN, Fleshner N, Fizazi K, Rébillard X, Dogliotti L, Conti G, Turesson I, James N, Heidenreich A, Solsona E, Guillem V, Herchenhorn D, Moul J, van Moorselaar J, Coetzee LJ, Wilson A, Bamias A, De Wit R, Chrisofos M. Fitzpatrick JM, et al. Among authors: moul j. Crit Rev Oncol Hematol. 2008 Oct;68 Suppl 1:S9-S22. doi: 10.1016/j.critrevonc.2008.07.019. Epub 2008 Aug 23. Crit Rev Oncol Hematol. 2008. PMID: 18723368 Review.

2

Prognostic factors in low-stage nonseminomatous testicular cancer.

Moul JW, Heidenreich A. Moul JW, et al. Oncology (Williston Park). 1996 Sep;10(9):1359-68, 1374; discussion 1377-8. Oncology (Williston Park). 1996. PMID: 8882926 Free article. Review.

3

The influence of ejaculation on serum levels of prostate specific antigen.

Heidenreich A, Vorreuther R, Neubauer S, Westphal J, Engelmann UH, Moul JW. Heidenreich A, et al. Among authors: moul jw. J Urol. 1997 Jan;157(1):209-11. J Urol. 1997. PMID: 8976253

4

Prognostic risk factors in low stage testicular germ cell tumors: unanswered questions regarding clinically useful prognosticators for extratesticular disease.

Heidenreich A, Sesterhenn IA, Moul JW. Heidenreich A, et al. Among authors: moul jw. Cancer. 1997 May 1;79(9):1641-5; discussion 1646. doi: 10.1002/(sici)1097-0142(19970501)79:9<1641::aid-cncr1>3.0.co;2-f. Cancer. 1997. PMID: 9128977 Review. No abstract available.

5

Contralateral testicular biopsy procedure in patients with unilateral testis cancer: is it indicated?

Heidenreich A, Moul JW. Heidenreich A, et al. Semin Urol Oncol. 2002 Nov;20(4):234-8. doi: 10.1053/suro.2002.36980. Semin Urol Oncol. 2002. PMID: 12489055 Review.

6

Early prostate cancer: prevention, treatment modalities, and quality of life issues.

Moul JW, Anderson J, Penson DF, Klotz LH, Soloway MS, Schulman CC. Moul JW, et al. Eur Urol. 2003 Sep;44(3):283-93. doi: 10.1016/s0302-2838(03)00296-3. Eur Urol. 2003. PMID: 12932925 Review.

7

Background for the proposal of SIOG guidelines for the management of prostate cancer in senior adults.

Droz JP, Balducci L, Bolla M, Emberton M, Fitzpatrick JM, Joniau S, Kattan MW, Monfardini S, Moul JW, Naeim A, van Poppel H, Saad F, Sternberg CN. Droz JP, et al. Crit Rev Oncol Hematol. 2010 Jan;73(1):68-91. doi: 10.1016/j.critrevonc.2009.09.005. Crit Rev Oncol Hematol. 2010. PMID: 19836968 Review.

8

Management of prostate cancer in older men: recommendations of a working group of the International Society of Geriatric Oncology.

Droz JP, Balducci L, Bolla M, Emberton M, Fitzpatrick JM, Joniau S, Kattan MW, Monfardini S, Moul JW, Naeim A, van Poppel H, Saad F, Sternberg CN. Droz JP, et al. BJU Int. 2010 Aug;106(4):462-9. doi: 10.1111/j.1464-410X.2010.09334.x. Epub 2010 Mar 25. BJU Int. 2010. PMID: 20346033 Free PMC article. Review.

9

Maximizing outcomes in genitourinary cancers across the treatment continuum.

Fitzpatrick JM, Bellmunt J, Dreicer R, Fleshner NE, Logothetis CJ, Moul JW, Tombal B, Zlotta A. Fitzpatrick JM, et al. Among authors: moul jw. BJU Int. 2011 Apr;107 Suppl 2:1-12. doi: 10.1111/j.1464-410X.2010.10035.x. BJU Int. 2011. PMID: 21382149

10

Detection of previously unidentified metastatic disease as a leading cause of screening failure in a phase III trial of zibotentan versus placebo in patients with nonmetastatic, castration resistant prostate cancer.

Yu EY, Miller K, Nelson J, Gleave M, Fizazi K, Moul JW, Nathan FE, Higano CS. Yu EY, et al. Among authors: moul jw. J Urol. 2012 Jul;188(1):103-9. doi: 10.1016/j.juro.2012.03.008. Epub 2012 May 12. J Urol. 2012. PMID: 22583636 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

567 results

Search Page